Toxicity of nanoparticles depends on many factors including size, shape, chemical composition, surface area,surface charge. and others. In this study, we compared the toxicity of different sized-silver nanopartcles (AgNPs) which are being widely used in consumer products clue to its unique antimicrobial activity When mice were treated with AgNPs 1 mg/kg for 14 days by oral administration, small-sized AgNPs (22 nm, 42 nm, and 71 nm) were distributed to the organs including brain, lung, liver, kidney, and testis while large-sized AgNPs (323 nm) were not detected in those tissues. The levels of TGF-beta in serum were also significantly increased in the treated group of small-sized AgNPs but not in large-sized AgNPs In addition, B cell distribution was Increased in small-sized AgNPs but not in large-sized-AgNPs by the phenotype analysis However, body weight or in the ratio of organ/body weight were not different between the control group and all the AgNPs-treated groups The repeated-dose toxicity of AgNPs (42 nm) was also investigated in mice by oral administration for 28 clays By the administration of AgNPs (0.25 mg/kg, 050 mg/kg, 1 00 mg/kg), adverse impacts on liver and kidney were observed in a high dose-treated group (1 00 mg/kg), when determined by blood chemistry and histipathological analysis Cytokines including IL-1, IL-6, IL-4, IL-10, IL-12. and TGF-beta were also increased in a dose-dependent manner by repeated oral administration In addition, B cell distribution in lymphocyte and IgE production were increased Based on these results, it is suggested that repeated oral administration of nano-sized AgNPs may cause organ toxicity and inflammatory responses in mice (C) 2010 Elsevier B V All rights reserved.